Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0012833 (
dizziness
)
9,689
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Metabolic therapy is one of several therapeutic strategies that can be used in patients with lower limb chronic obliterative arterial disease (COAD).
Tanakan
(EGb76) has demonstrated high efficiency and safety in 9 controlled clinical trials and author's clinical series in patients with lower limb COAD. Improvement with significant increase of pain-free walking distance and beneficial safety profile was observed in all cases.
Tanakan
(EGb76) is highly effective conventional therapeutic agent for memory and attention disorders,
dizziness
and balance disturbances in adults and elderly patients. Given a common concomitance of these disorders and lower limb COAD,
Tanakan
can be recommended as a drug of choice for treatment of chronic obliterative arteriopathy.
...
PMID:[Antioxidant and metabolic therapy of lower limb chronic obliterative arterial disease]. 1764 11
The objective of the present study was to estimate the influence of tanakan on the duration of the period needed to achieve vestibular compensation in the patients presenting with peripheral vestibular
dizziness
in the course of vestibular rehabilitation with the use of the post-urographic system. 72 patients at the age varying from 18 to 42 years (46 women and 26 men) suffering from peripheral vestibular
dizziness
were treated on an individual basis for the purpose of vestibular rehabilitation 3-5 times per week for a total period of 3-6 weeks. 42 of the 72 patients comprising group 1 were given
Tanakan
for 3 months at a dose of 40 mg thrice daily, the remaining 30 patients (group 2) continued to receive the vasoactive treatment as prescribed by attending physicians of other medical and diagnostic centres (protocols of their treatment recommended at local medical facilities did not include tanakan therapy). It is concluded that the use of tanakan for the treatment of the patients presenting with peripheral vestibular
dizziness
accelerates vestibular compensation and reduces the time necessary to achieve vestibular rehabilitation. Moreover, the combined treatment with the application of tanakan makes it possible to decrease the medicamental loading.
...
PMID:[The role of tanakan in the improvement of the effectiveness of vestibular rehabilitation]. 2558 91
A 60-year-old female patient living in Southeast China presented with persistent fever, chills, night sweats, fatigue, and
dizziness
of 12-day duration. Blood tests showed neutropenia, thrombocytopenia, and active hemolytic anemia, with elevated C-reactive protein. Broad-spectrum antibiotics were administered for a possible diagnosis of sepsis, without any response. Malaria was initially diagnosed after visualizing intraerythrocytic ring-shaped parasites in bone marrow and blood smears. The patient resided in an area of unstable endemicity for Plasmodium falciparum. Blood samples were sent to the Centers for Disease Control and Prevention and a definitive diagnosis of human babesiosis was made using Babesia microti-specific PCR.
Chloroquine phosphate
and clindamycin were started and the patient became normothermic. However, due to the intolerable adverse effects of the antibiotics, intravenous azithromycin was given as an alternative. The patient recovered from fever and hemolysis, and repeated peripheral blood smears showed hemoparasite clearance. Cases of human babesiosis are rarely reported and probably under-diagnosed in China; therefore, improving our understanding of this disease as a newly emerging public health threat is imperative.
...
PMID:Human babesiosis in Southeast China: A case report. 2935 31